Articles in Aim to Cure
A statistical modeling study suggests that problems with alcohol abuse may lead to an increased risk of depression, as opposed to the reverse model in which individuals with depression self-medicate with alcohol, according to a …
Arthritis affects more than half of adults with heart disease and appears to be a substantial barrier to utilizing physical activity to help manage their condition, according to a new study. According to the Arthritis …
High levels of a protein linked to the way pain signals are sent to the brain led to a decrease in abdominal pain in a recent study in mice. Researchers say the finding suggests the …
High levels of a protein linked to the way pain signals are sent to the brain led to a decrease in abdominal pain in a recent study in mice. Researchers say the finding suggests the …
Women in strained marriages are more likely to feel depressed and suffer high blood pressure, obesity and other signs of “metabolic syndrome,” a group of risk factors for heart disease, stroke and diabetes, psychologists found. …
Common sense suggests that extra body weight severely stresses bones and joints. This higher, unprecedented level of obesity in the U.S. has affected the number of total hip replacements, implanted to restore mobility and relieve …
Protection against Ebola, one of the world’s deadliest viruses, can be achieved by a vaccine produced in insect cells, raising prospects for developing an effective vaccine for humans, according to new research.
A new study provides insight into how a short burst in nitrite can exert lasting beneficial effects on the heart, protecting it from stress and assaults such as heart attacks. Researchers have demonstrated for the …
Bypassing a molecular breakdown that helps trigger autoimmunity could lead to new treatments for autoimmune disorders and chronic infections that sicken or kill thousands of children annually, according to researchers. Scientists have discovered genetic evidence …
Scientists have revealed that mutations in a gene called fused in sarcoma cause familial motor neuron disease. This is the second gene to be discovered from MND in the Shaw laboratory in just one year …
The US Food and Drug Administration (FDA) has approved a 30-minute onset of action for Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), bringing potential benefits for young patients …
Portola Pharmaceuticals, a biopharmaceutical company developing innovative drugs that provide significant advances in cardiovascular and inflammatory diseases, and cancer, announced new clinical data that demonstrate PRT060128, the Company’s novel anti-platelet drug that directly and reversibly …
ViroPharma Incorporated (Nasdaq: VPHM) announced the presentation of data from its ongoing, open-label study, showing that in this study Cinryze(TM) C1 inhibitor therapy successfully treated all types of acute hereditary angioedema (HAE) attacks seen in …
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from a Phase 1a clinical trial of MBX-2982. A summary of …
Raptor Pharmaceuticals Corp. (”Raptor” or the “Company”) (OTC Bulletin Board: RPTP), announced positive results in its Phase IIa study of oral 4-methylpyrazole (”4-MP”) in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development …
Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), presented Phase I data last week during the Retina Subspecialty Day at the American Academy of Ophthalmology (AAO) …
Phase I results of the first clinical trial of gene therapy for patients with advanced heart failure show the approach to be promising, with improvements in several measures of the condition’s severity.
In Phase I clinical …
Many large pharmaceutical companies plan to increase their efforts to develop HIV/AIDS drugs and diagnostics for impoverished regions.
